- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2038-3274
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Next-generation anti-CD20 monoclonal antibodies in autoimmune disease treatment ; volume:8 ; number:1 ; day:16 ; month:11 ; year:2017 ; pages:1-12 ; date:12.2017
Autoimmunity highlights ; 8, Heft 1 (16.11.2017), 1-12, 12.2017
- Classification
-
Medizin, Gesundheit
- Creator
-
Du, Fanny Huynh
- Contributor
- DOI
-
10.1007/s13317-017-0100-y
- URN
-
urn:nbn:de:1111-201802095542
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:04 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Du, Fanny Huynh
- Mills, Elizabeth A.
- Mao-Draayer, Yang
- SpringerLink (Online service)
Other Objects (12)
Novel CD20 monoclonal antibodies for lymphoma therapy
A Milestone in Multiple Sclerosis Therapy: Monoclonal Antibodies Against CD20—Yet Progress Continues
A Milestone in Multiple Sclerosis Therapy: Monoclonal Antibodies Against CD20—Yet Progress Continues
Therapeutic potential of CD20/CD3 bispecific antibodies in the treatment of autoimmune diseases
Monoclonal antibodies
Systematic literature review of immunoglobulin trends for anti-CD20 monoclonal antibodies in multiple sclerosis
Key characteristics of anti-CD20 monoclonal antibodies and clinical implications for multiple sclerosis treatment
Monoclonal antibodies in transplantation
Glycoengineering of Monoclonal Antibodies
A novel glycosylated anti-CD20 monoclonal antibody from transgenic cattle
Neonatal B-cell levels and infant health in newborns potentially exposed to anti-CD20 monoclonal antibodies during pregnancy or lactation
Clinical relevance of new monoclonal antibodies
Novel CD20 monoclonal antibodies for lymphoma therapy
A Milestone in Multiple Sclerosis Therapy: Monoclonal Antibodies Against CD20—Yet Progress Continues
A Milestone in Multiple Sclerosis Therapy: Monoclonal Antibodies Against CD20—Yet Progress Continues
Therapeutic potential of CD20/CD3 bispecific antibodies in the treatment of autoimmune diseases
Monoclonal antibodies
Systematic literature review of immunoglobulin trends for anti-CD20 monoclonal antibodies in multiple sclerosis
Key characteristics of anti-CD20 monoclonal antibodies and clinical implications for multiple sclerosis treatment
Monoclonal antibodies in transplantation
Glycoengineering of Monoclonal Antibodies
A novel glycosylated anti-CD20 monoclonal antibody from transgenic cattle
Neonatal B-cell levels and infant health in newborns potentially exposed to anti-CD20 monoclonal antibodies during pregnancy or lactation
Clinical relevance of new monoclonal antibodies
Novel CD20 monoclonal antibodies for lymphoma therapy
A Milestone in Multiple Sclerosis Therapy: Monoclonal Antibodies Against CD20—Yet Progress Continues
A Milestone in Multiple Sclerosis Therapy: Monoclonal Antibodies Against CD20—Yet Progress Continues
Therapeutic potential of CD20/CD3 bispecific antibodies in the treatment of autoimmune diseases
Monoclonal antibodies
Systematic literature review of immunoglobulin trends for anti-CD20 monoclonal antibodies in multiple sclerosis
Key characteristics of anti-CD20 monoclonal antibodies and clinical implications for multiple sclerosis treatment
Monoclonal antibodies in transplantation
Glycoengineering of Monoclonal Antibodies
A novel glycosylated anti-CD20 monoclonal antibody from transgenic cattle
Neonatal B-cell levels and infant health in newborns potentially exposed to anti-CD20 monoclonal antibodies during pregnancy or lactation